Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mika Yamauchi

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Clinical Calcium|May 28, 2016
[The Importance of teriparatide in the treatment of osteoporosis]Mika Yamauchi
Clinical Calcium|July 4, 2007
[Absolute risk for fracture and WHO guideline. Treatment of patients with secondary osteoporosis]Mika Yamauchi,
Clinical Calcium|July 30, 2009
[Biochemical markers of bone turnover. New aspect. Biochemical bone markers of bone in patients treated with glucocorticoid]Mika Yamauchi
Clinical Calcium|October 1, 2018
[Rickets/Osteomalacia. Non-skeletal effects of vitamin D.]Mika Yamauchi
Clinical Calcium|January 6, 2016
[The assessment of bone quality in lifestyle-related diseases]Mika Yamauchi
Clinical Calcium|September 1, 2015
[On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Osteoporosis associated with lifestyle-related diseases: other lifestyle-related diseases]Mika Yamauchi
Clinical Calcium|November 30, 2018
[Secondary osteoporosis. Glucocorticoid excess-related osteoporosis.]Mika Yamauchi
Clinical Calcium|April 29, 2014
[Epidemiology of bone and joint disease - the present and future - . Risk and prevention/treatment of fractures associated with lifestyle-related diseases]Mika Yamauchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 5, 2015
[Status and issues of medical treatment for osteoporosis]Mika Yamauchi, Toshitsugu Sugimoto
Clinical Calcium|March 19, 2005
[Significance of bone mass measurement in glucocorticoid-induced osteoporosis]Mika Yamauchi, Toshitsugu Sugimoto
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Clinical Calcium|May 28, 2016
[The Importance of teriparatide in the treatment of osteoporosis]Mika Yamauchi
Clinical Calcium|July 4, 2007
[Absolute risk for fracture and WHO guideline. Treatment of patients with secondary osteoporosis]Mika Yamauchi,
Clinical Calcium|July 30, 2009
[Biochemical markers of bone turnover. New aspect. Biochemical bone markers of bone in patients treated with glucocorticoid]Mika Yamauchi
Clinical Calcium|October 1, 2018
[Rickets/Osteomalacia. Non-skeletal effects of vitamin D.]Mika Yamauchi
Clinical Calcium|January 6, 2016
[The assessment of bone quality in lifestyle-related diseases]Mika Yamauchi
Clinical Calcium|September 1, 2015
[On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Osteoporosis associated with lifestyle-related diseases: other lifestyle-related diseases]Mika Yamauchi
Clinical Calcium|November 30, 2018
[Secondary osteoporosis. Glucocorticoid excess-related osteoporosis.]Mika Yamauchi
Clinical Calcium|April 29, 2014
[Epidemiology of bone and joint disease - the present and future - . Risk and prevention/treatment of fractures associated with lifestyle-related diseases]Mika Yamauchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 5, 2015
[Status and issues of medical treatment for osteoporosis]Mika Yamauchi, Toshitsugu Sugimoto
Clinical Calcium|March 19, 2005
[Significance of bone mass measurement in glucocorticoid-induced osteoporosis]Mika Yamauchi, Toshitsugu Sugimoto
Pageof 11